120 related articles for article (PubMed ID: 24025106)
21. Advances in targeting strategies for nanoparticles in cancer imaging and therapy.
Yhee JY; Lee S; Kim K
Nanoscale; 2014 Nov; 6(22):13383-90. PubMed ID: 25273283
[TBL] [Abstract][Full Text] [Related]
22. Theoretical Formulation Strategies towards Neutralizing Inter-individual Variability Associated with Tacrolimus Immunosuppressant Therapy: A Case Study on Nextgeneration Personalized Medicine.
Radhakrishnan A; Kuppusamy G
Curr Drug Metab; 2021; 22(12):939-956. PubMed ID: 34779367
[TBL] [Abstract][Full Text] [Related]
23. Personalized medicine in oncology, the potential role of nuclear medicine imaging.
Van de Wiele C; Mees G
Curr Pharm Des; 2014; 20(14):2231-3. PubMed ID: 24025097
[No Abstract] [Full Text] [Related]
24. Imaging requirements for personalized medicine: the oncologists point of view.
Kruse V; Belle SV; Cocquyt V
Curr Pharm Des; 2014; 20(14):2234-49. PubMed ID: 24025098
[TBL] [Abstract][Full Text] [Related]
25. Real-time analysis of G protein-coupled receptor signaling in live cells.
Jala VR; Haribabu B
Methods Mol Biol; 2006; 332():159-65. PubMed ID: 16878691
[TBL] [Abstract][Full Text] [Related]
26. The immune system and cancer: the evolving role of molecular imaging and molecular targeted therapy.
Lucignani G
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):503-5. PubMed ID: 16596377
[No Abstract] [Full Text] [Related]
27. Imaging of cerebrovascular disorders: precision medicine and the collaterome.
Liebeskind DS; Feldmann E
Ann N Y Acad Sci; 2016 Feb; 1366(1):40-8. PubMed ID: 25922154
[TBL] [Abstract][Full Text] [Related]
28. Covalent molecular probes for class A G protein-coupled receptors: advances and applications.
Weichert D; Gmeiner P
ACS Chem Biol; 2015 Jun; 10(6):1376-86. PubMed ID: 25860503
[TBL] [Abstract][Full Text] [Related]
29. Development of a universal high-throughput calcium assay for G-protein- coupled receptors with promiscuous G-protein Galpha15/16.
Zhu T; Fang LY; Xie X
Acta Pharmacol Sin; 2008 Apr; 29(4):507-16. PubMed ID: 18358098
[TBL] [Abstract][Full Text] [Related]
30. Fluorescent ligands for G protein-coupled receptors: illuminating receptor-ligand interactions for drug discovery.
Stoddart LA; Briddon SJ; Hill SJ
Future Med Chem; 2013 Aug; 5(12):1367-9. PubMed ID: 23919546
[No Abstract] [Full Text] [Related]
31. Medicine's secret ingredient - it's in the timing.
Peeples L
Nature; 2018 Apr; 556(7701):290-292. PubMed ID: 29666501
[No Abstract] [Full Text] [Related]
32. [Regulation of pharmacokinetics and targeting-confirmative personalized medicine].
Kawai K
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2011; 67(3):249-59. PubMed ID: 21471682
[No Abstract] [Full Text] [Related]
33. A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes.
Schneider E; Mayer M; Ziemek R; Li L; Hutzler C; Bernhardt G; Buschauer A
Chembiochem; 2006 Sep; 7(9):1400-9. PubMed ID: 16888730
[TBL] [Abstract][Full Text] [Related]
34. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
[TBL] [Abstract][Full Text] [Related]
35. SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approach.
Werner RA; Bluemel C; Lassmann M; Kudlich T; Higuchi T; Lopci E; Allen-Auerbach M; Colletti PM; Rubello D; Zatelli MC; Herrmann K
Clin Nucl Med; 2015 May; 40(5):e271-7. PubMed ID: 25642915
[TBL] [Abstract][Full Text] [Related]
36. Radiolabelled chemotherapeutics.
Rottey S; Signore A; Van de Wiele C
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):139-51. PubMed ID: 17420715
[TBL] [Abstract][Full Text] [Related]
37. Unmet needs in developing nanoparticles for precision medicine.
Schwartz S
Nanomedicine (Lond); 2017 Feb; 12(4):271-274. PubMed ID: 28093937
[No Abstract] [Full Text] [Related]
38. Liposome imaging agents in personalized medicine.
Petersen AL; Hansen AE; Gabizon A; Andresen TL
Adv Drug Deliv Rev; 2012 Oct; 64(13):1417-35. PubMed ID: 22982406
[TBL] [Abstract][Full Text] [Related]
39. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization.
Hensing T; Chawla A; Batra R; Salgia R
Adv Exp Med Biol; 2014; 799():85-117. PubMed ID: 24292963
[TBL] [Abstract][Full Text] [Related]
40. Nuclear imaging in cancer theranostics.
Del Vecchio S; Zannetti A; Fonti R; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):152-63. PubMed ID: 17420716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
